Marta Trevisan builds human neural cell and organoid platforms to probe host-pathogen interactions and assess antivirals. She applies CRISPR and viral vectors to model neurodegeneration and uses imaging-based phenotyping to map neuroinflammation, mitophagy, and neurotoxicity.